The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 16 investment research firms has been aggregated, with new reports being added and updated constantly
Current Share Price: 12.070 
Bonitas Research
Initial Report Date(2023/02/22)Share Price:16.960  
HARROW HEALTH – $HROW – LATEST IDEA – FEBRUARY 22, 2023
 Details Link >
Harrow burns cash from operations and relies on external financing for survival. We think Harrow did not disclose to investors the existence of a DOJ investigation because it would have compromised Harrow’s ability to raise capital. With significant liabilities managed by bad actors willing to enrich themselves at the expense of minority Harrow shareholders, we are short Harrow and think its stock is going lower.
By wantattse 
QTinsight - Customized Global Investment Research
QTinsight.com and all of its information providers will not be liable for any errors,omissions,delays or interruptions in all the information and data on the QTinsight.com website or for any damages relating to your use of the information provided herein. All data,research findings,opinions and information herein, whether provided by QTinsight.com or by its users,should not be treated as professional investment advice.